Skip to content

Welcome Allucent as a new corporate member

Date: November 14, 2023

The ACDM: Association for Clinical Data Management is delighted to welcome Allucent as a new corporate member.

Allucent is a Contract Research Organisation that focuses on small and mid-sized biotech. Designed to serve smaller companies, Allucent offers capabilities and expertise that mirror those of larger CROs, but delivered with a more personal and flexible style tailored for the client. Working collaboratively, Allucent stays close to the science that drives therapeutic innovation.

Members gain many benefits from membership, including:

  • Access to training courses at a discounted rate
  • Assign full ACDM membership to all individuals within your organisation
  • Place an organisation profile, description and logo on the ACDM website
  • Advertise jobs for your positions within your organisation
  • Reduced price attendance at conferences and symposia
  • Free attendance at Hot Topics

Find out more about becoming a corporate member here.

 


 

Explore More News

Welcome The Institute of Cancer Research – Scientific Computing as a corporate member

The Association for Clinical Data Management (ACDM) is delighted to welcome The Institute . . .

Read More

Newsletter Committee: Meet Federica

The ACDM is delighted to welcome Federica Migliore of IQVIA to the Newsletter . . .

Read More

Welcome P95 as a corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome P95 as a new . . .

Read More

AI Symposium Session Summary: Is AI in clinical trials delivering measurable ROI?

At the 4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials, the . . .

Read More

Newsletter Committee: Meet Neha

The ACDM is delighted to welcome Neha Shah of ITM to the Newsletter Committee. Neha shares . . .

Read More

Newsletter Committee: Meet Sylvain

The ACDM is delighted to welcome Sylvain Berthelot of CRScube to the Newsletter . . .

Read More

Welcome VHypotenuse as a corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome VHypotenuse as . . .

Read More

Newsletter Committee: Meet Marta

The ACDM is delighted to welcome Marta Kowalska of CluePoints to the Newsletter . . .

Read More

AI model trained on de-identified data from 57 million people

Researchers at UCL have trained an AI model using de-identified data from 57 million . . .

Read More

ACDM Regulatory Considerations DMEG Update: ICH E6 (R3) GCP Final Publication Released

The final publication of ICH E6 (R3) Good Clinical Practice (GCP) General Principles and . . .

Read More

ICH E6(R3) Guideline reaches Step 4 of the ICH Process

ICH E6(R3) reaches Step 4 of the ICH Process on 6th January 2025. The guideline . . .

Read More

U.S. Food & Drug Administration: Draft Guidance for Industry and Other Interested Parties

The U.S. Food and Drug Administration has issued its first guidance on the use of . . .

Read More